Glenmark Pharmaceuticals2461.40
+11.40 (+0.47%)

Glenmark Pharmaceuticals Share Price

2461.40+11.40 (+0.47%)
+18.04% past 1 Year

Corporate filings & documents

Announcements

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Schedule of Analyst/ Institutional Investor Meetings
1 day ago
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Schedule of Analyst/ Institutional Investor Meetings
1 day ago
Report of Scrutinizer is enclosed
1 week ago
Report of Scrutinizer is enclosed
1 week ago
Proceedings of the 48th AGM of the Company is enclosed
1 week ago
Proceedings of the 48th AGM of the Company is enclosed
1 week ago
Glenmark expands Global Respiratory Innovation Footprint with RYALTRIS launch in Brazil
1 week ago
Glenmark expands Global Respiratory Innovation Footprint with RYALTRIS launch in Brazil
1 week ago
Please find enclosed rating rationale issued by India Ratings and Research
1 week ago
Please find enclosed rating rationale issued by India Ratings and Research
1 week ago
Glenmark Pharmaceuticals Inc. USA launches Calcium Gluconate Injection USP 1 000 mg/10 mL (100 mg/mL) 5 000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10 000 mg/100 mL (100 mg/mL) Pharmacy Bulk Package
1 month ago
Glenmark Pharmaceuticals Inc. USA launches Calcium Gluconate Injection USP 1 000 mg/10 mL (100 mg/mL) 5 000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10 000 mg/100 mL (100 mg/mL) Pharmacy Bulk Package
1 month ago
Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray 0.05 mg (50 mcg)/spray
1 month ago
Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray 0.05 mg (50 mcg)/spray
1 month ago
Newspaper Advertisement regarding the 48th Annual General Meeting ("AGM") to be held on Friday September 11 2026 at 2.00 p.m. through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM")
1 month ago
Newspaper Advertisement regarding the 48th Annual General Meeting ("AGM") to be held on Friday September 11 2026 at 2.00 p.m. through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM")
1 month ago
Letter to Shareholders whose email address are not registered providing the web link of Annual Report
1 month ago
Letter to Shareholders whose email address are not registered providing the web link of Annual Report
1 month ago
Please find attached Business Responsibility and Sustainability Reporting for Financial Year 2025-26
1 month ago
Please find attached Business Responsibility and Sustainability Reporting for Financial Year 2025-26
1 month ago
Please find attached Notice convening the 48th Annual General Meeting and the Integrated Annual Report including BRSR for the Financial Year 2025-26.
1 month ago
Please find attached Notice convening the 48th Annual General Meeting and the Integrated Annual Report including BRSR for the Financial Year 2025-26.
1 month ago
Please find attached Notice of 48th Annual General Meeting for the Financial Year 2025-26
1 month ago
Please find attached Notice of 48th Annual General Meeting for the Financial Year 2025-26
1 month ago
Settlement Agreement - Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015
1 month ago
Intimation of Allotment of shares under the Employee Stock Option Plan 2016
1 month ago
Intimation of Allotment of shares under the Employee Stock Option Plan 2016
1 month ago
Intimation of Schedule of Analyst / Institutional Investor Meetings
1 month ago
Intimation of Schedule of Analyst / Institutional Investor Meetings
1 month ago
Newspaper Advertisement regarding the 48th Annual General Meeting ("the AGM") to held through Video Conferencing ("VC")/ Other Audio-Visual Means ("OAVM")
1 month ago
Newspaper Advertisement regarding the 48th Annual General Meeting ("the AGM") to held through Video Conferencing ("VC")/ Other Audio-Visual Means ("OAVM")
1 month ago
Transcript of the Earnings Call
1 month ago
Transcript of the Earnings Call
1 month ago
Audio recording of Q1 FY 2026-27 Earnings Call held on August 03 2026
1 month ago
Audio recording of Q1 FY 2026-27 Earnings Call held on August 03 2026
1 month ago
The Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30 2026 have been published in Financial Express and Loksatta newspapers on Saturday August 1 2026.
1 month ago
The Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30 2026 have been published in Financial Express and Loksatta newspapers on Saturday August 1 2026.
1 month ago
Investor Presentation - Q1 FY 26-27
1 month ago
Investor Presentation - Q1 FY 26-27
1 month ago
Please find attached Press Release and Management Discussion & Analysis for the first quarter ended June 30 2026
1 month ago
Please find attached Press Release and Management Discussion & Analysis for the first quarter ended June 30 2026
1 month ago
Please find attached Companys officials authorised for the purpose of determining materiality of an event or information and making disclosures to the Stock Exchanges
1 month ago
Please find attached Companys officials authorised for the purpose of determining materiality of an event or information and making disclosures to the Stock Exchanges
1 month ago
Intimation of Record Date for Dividend
1 month ago
Intimation of Record Date for Dividend
1 month ago
The Board of Directors has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026
1 month ago
The Board of Directors has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026
1 month ago
Glenmark Pharmaceuticals Inc. USA launches Sugammadex Injection 200 mg/2mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
1 month ago
Glenmark Pharmaceuticals Inc. USA launches Sugammadex Injection 200 mg/2mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
1 month ago
Newspaper advertisement for transfer of shares to IEPF Authority
1 month ago

Concalls & investor presentations

Aug 2026
ConcallPresentation
Jul 2026
Jun 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Jan 2026
Aug 2025
ConcallPresentation
Aug 2025
May 2025
ConcallPresentation
May 2025
Feb 2025
ConcallPresentation
Feb 2025
Nov 2024
ConcallPresentation
Nov 2024
Aug 2024
ConcallPresentation
Aug 2024
May 2024
ConcallPresentation
May 2024
Feb 2024
ConcallPresentation
Feb 2024
Nov 2023
ConcallPresentation
Nov 2023
Aug 2023
ConcallPresentation
Aug 2023
May 2023
ConcallPresentation
May 2023
Feb 2023
ConcallPresentation
Feb 2023
Nov 2022
ConcallPresentation
Nov 2022
Aug 2022
ConcallPresentation
Aug 2022
May 2022
ConcallPresentation
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Feb 2021
Nov 2020

Glenmark Pharmaceuticals Ltd Share Price Today

The Glenmark Pharmaceuticals Ltd share price today is ₹2455.80. During the trading session, the Glenmark Pharmaceuticals Ltd share price opened at ₹2420.20 and recorded an intraday high of ₹2472.00 and a low of ₹2420.20. Last closing price was ₹2437.20. Over the past 52 weeks, the Glenmark Pharmaceuticals Ltd share price has ranged between ₹1792.60 and ₹2537.60. The current Glenmark Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.